| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue |
-
|
-
| 111 | | Cost of Revenue |
-
| 1,260 |
-
| | | Gross Profit |
-
| (1,260) | 111 | | | Operating Expenses | | Research Development | 12,587 | 12,108 | 17,186 | | Selling General and Administrative | 14,975 | 18,195 | 13,845 | | Non Recurring | 367 | 8,784 | 611 | | Others | 251 | 386 |
-
| | | | Total Operating Expenses | 28,180 | 39,473 |
-
| | | | Operating Income or Loss | (28,180) | (40,733) | (31,531) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,304 | 2,272 | 7,027 | | Earnings Before Interest And Taxes | (19,876) | (38,461) | (24,504) | | Interest Expense | 819 | 176 | 2 | | Income Before Tax | (20,695) | (38,637) | (24,506) | | Income Tax Expense | (674) | (837) | (799) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (20,021) | (37,800) | (23,707) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (20,021) | (37,800) | (23,707) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($20,021) | ($37,800) | ($23,707) |
|
0.31% Nasdaq 
0.05%
Income Statement
